Journal of Rheumatic Diseases

Cited by CrossRef (8)

  1. Yun-Hee Han, Hyeon-Jun Woo, Soo-Yeon Park, Chang-Hoon Lee, Chong-Hyuk Chung, Myeung-Su Lee, Jung-Han Lee. Korean Domestic Trends in Clinical Research on Rheumatoid Arthritis since 2008. J Korean Med Rehabil 2021;31:18
    https://doi.org/10.18325/jkmr.2021.31.3.19
  2. In Ah Choi. Comparison of the Disease Activity Score-28 Based on the Erythrocyte Sedimentation Rate and C-reactive Protein in Rheumatoid Arthritis. J Rheum Dis 2017;24:287
    https://doi.org/10.4078/jrd.2017.24.5.287
  3. Young Ho Lee, Gwan Gyu Song. Relative remission rates of Janus kinase inhibitors in comparison with adalimumab in patients with active rheumatoid arthritis: a network meta-analysis. Z Rheumatol 2024;83:88
    https://doi.org/10.1007/s00393-022-01165-w
  4. Sang-Cheol Bae, Young Ho Lee. Calprotectin levels in rheumatoid arthritis and their correlation with disease activity: a meta-analysis. Postgraduate Medicine 2017;129:531
    https://doi.org/10.1080/00325481.2017.1319729
  5. Hae-Rim Kim. The Need for New Criteria to Define Disease Activity and Treatment Response Using Disease Activity Score (DAS)28-C-reactive Protein. J Rheum Dis 2016;23:277
    https://doi.org/10.4078/jrd.2016.23.5.277
  6. Young Ho Lee, Gwan Gyu Song. Comparison of the efficacy and safety of olokizumab at different dosages in patients with active rheumatoid arthritis: a network meta-analysis of randomized controlled trials. Z Rheumatol 2024;83:107
    https://doi.org/10.1007/s00393-023-01367-w
  7. S.-C. Bae, Y. H. Lee. Comparative efficacy and tolerability of sarilumab 150 and 200 mg in patients with active rheumatoid arthritis. Z Rheumatol 2018;77:421
    https://doi.org/10.1007/s00393-017-0292-6
  8. Young Ho Lee. Comparison of Disease Activity Score-28 Based on Erythrocyte Sedimentation Rate and C-reactive Protein Level in Rheumatoid Arthritis. J Rheum Dis 2018;25:1
    https://doi.org/10.4078/jrd.2018.25.1.1